Anti-human T lymphocyte immunglobulin (Neovii Biotech)

抗人T细胞兔免疫球蛋白

Report date: 2024/12/11 16:30:20

Base Information

Drug NameAnti-human T lymphocyte immunglobulin (Neovii Biotech)
Drug Alias Name兔抗人T淋巴细胞球蛋白ATG-S-FreseniusATeGe-FreseniusATG-Fresenius SolutionAntithymocyte globulin (Fresenius Biotech) +[16] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseMyelodysplastic Syndromes +[10] 
Global Approved IndicationsRejection of organ transplantationGraft vs Host Disease
Approved Indications in ChinaRejection of organ transplantation
Original Approved Country/TerritoryGermany
Original Approved Date1988/01/01
Country/TerritoryCanadaUnited StatesSweden +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNeovii Biotech Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesScandinavian Biopharma AbNeovii Biotech GmbhShanghai Fosun Pharmaceutical Industrial Development Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationGraft vs Host Disease
Inactive IndicationsMyelodysplastic SyndromesIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive +[8] 

Other Information

ATC CodeL04AA04
Related LinksN/A